Cells destined to form the coronary vessels reside in the pro-epicardial organ (PEO) prior to migrating toe the developing heart tube. These cells form an epithelial layer over the heart and undergo epithelial- mesenchymal transformation and subsequent migration into the heart, followed by vessel formation. Similarly, the migration of neural crest cells into the heart is required for proper cardiogenesis, including coronary artery patterning and the septation of the outflow tract. We have shown that the Type III TGFb receptor (TBRIII) is required for epithelial- mesenchymal transformation and mesenchymal cell migration in the atrioventricular (AV) cushion of the heart. We will test the overall hypotheses that TBRIII is a mediator of epithelial-mesenchymal migration. We will use experimental embryological approaches in chick and genetic approaches in the mouse to gain a comprehensive understanding of the role of TBRIII in these events as they relate to coronary vessel development. Preliminary data in the chick demonstrate that TBRIII is expressed by both migrating neural crest cells and cells of the PEO. In addition, anti-TBRIII antisera inhibits the migration of neural crest cells in in vitro explant assays. The experiments we propose will determine the function of TBRIII in coronary vessel formation. The determination of which TGFb signal transduction complexes mediate cell transformation and cell migration will give general insight into TGFb signal transduction. Coronary vessel disease is a major cause of death in humans. A clearer understanding of coronary vessel development may identify novel approaches to treating coronary disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL067105-04
Application #
6893309
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
2004-05-01
Project End
2006-04-30
Budget Start
2004-05-01
Budget End
2005-04-30
Support Year
4
Fiscal Year
2004
Total Cost
$318,349
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Criswell, Tracy L; Dumont, Nancy; Barnett, Joey V et al. (2008) Knockdown of the transforming growth factor-beta type III receptor impairs motility and invasion of metastatic cancer cells. Cancer Res 68:7304-12
Hayashi, Hisaki; Kume, Tsutomu (2008) Foxc transcription factors directly regulate Dll4 and Hey2 expression by interacting with the VEGF-Notch signaling pathways in endothelial cells. PLoS One 3:e2401
Hayashi, Hisaki; Sano, Hideto; Seo, Seungwoon et al. (2008) The Foxc2 transcription factor regulates angiogenesis via induction of integrin beta3 expression. J Biol Chem 283:23791-800
Hayashi, Hisaki; Kume, Tsutomu (2008) Forkhead transcription factors regulate expression of the chemokine receptor CXCR4 in endothelial cells and CXCL12-induced cell migration. Biochem Biophys Res Commun 367:584-9
Austin, Anita F; Compton, Leigh A; Love, Joseph D et al. (2008) Primary and immortalized mouse epicardial cells undergo differentiation in response to TGFbeta. Dev Dyn 237:366-76
Compton, Leigh A; Potash, Dru A; Brown, Christopher B et al. (2007) Coronary vessel development is dependent on the type III transforming growth factor beta receptor. Circ Res 101:784-91
Fujita, Hideo; Kang, Myengmo; Eren, Mesut et al. (2006) Foxc2 is a common mediator of insulin and transforming growth factor beta signaling to regulate plasminogen activator inhibitor type I gene expression. Circ Res 98:626-34
Smith, Travis K; Bader, David M (2006) Characterization of Bves expression during mouse development using newly generated immunoreagents. Dev Dyn 235:1701-8
Compton, Leigh A; Potash, Dru A; Mundell, Nathan A et al. (2006) Transforming growth factor-beta induces loss of epithelial character and smooth muscle cell differentiation in epicardial cells. Dev Dyn 235:82-93
Seo, Seungwoon; Fujita, Hideo; Nakano, Atsushi et al. (2006) The forkhead transcription factors, Foxc1 and Foxc2, are required for arterial specification and lymphatic sprouting during vascular development. Dev Biol 294:458-70

Showing the most recent 10 out of 23 publications